908 Devices (NASDAQ:MASS) Releases Earnings Results, Beats Expectations By $0.03 EPS

908 Devices (NASDAQ:MASS) issued its quarterly earnings results on Tuesday. The company reported ($0.32) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.03, Zacks reports. 908 Devices had a negative return on equity of 24.60% and a negative net margin of 109.11%. 908 Devices updated its FY 2025 guidance to EPS.

908 Devices Price Performance

Shares of MASS stock opened at $3.51 on Tuesday. The company has a market capitalization of $122.05 million, a PE ratio of -1.98 and a beta of 0.99. The firm’s 50-day moving average is $2.42 and its two-hundred day moving average is $2.94. 908 Devices has a 12 month low of $1.81 and a 12 month high of $7.56.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on MASS. Leerink Partnrs downgraded shares of 908 Devices from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 13th. Leerink Partners reiterated a “market perform” rating and set a $4.00 price target (down previously from $12.00) on shares of 908 Devices in a research note on Wednesday, November 13th. Stephens reiterated an “overweight” rating and set a $6.00 price target on shares of 908 Devices in a research note on Wednesday, January 15th. Stifel Nicolaus dropped their target price on 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of 908 Devices in a report on Wednesday, February 19th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, 908 Devices currently has a consensus rating of “Moderate Buy” and an average price target of $5.33.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.